Diplopia: Clinical Trials

3 trials for Diplopia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 1, Recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Diplopia: new trials by email Literature Review of Diplopia trials Research Report on Diplopia

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene
Fampridine 10 mg prolonged-release tablet (per os), Placebo (tablets per os) - Spinocerebellar Ataxia 27B (SCA27B)
Phase 3RecruitingAssistance Publique - Hôpitaux de Paris702025-10-212025-12-10
Bupivacaine Injection of Eye Muscles to Treat Strabismus
Bupivacaine - Strabismus, Esotropia
Phase 2 / Phase 3UnknownSmith-Kettlewell Eye Research Institute1202012-04-012019-09-23
Idiopathic Intracranial Hypertension Treatment Trial
Acetazolamide, Placebo, Formal weight loss counselling program - Idiopathic Intracranial Hypertension
Phase 2 / Phase 3CompletedSt. Luke's-Roosevelt Hospital Center1652010-01-012018-12-12

Narrower conditions

Ataxia (1)  ·  Blepharoptosis (1)  ·  Esotropia (1)  ·  Exotropia (1)  ·  Graves Disease (1)  ·  Headache (1)  ·  Obesity (1)  ·  Papilledema (1)  ·  Pseudotumor Cerebri (1)  ·  Strabismus (1)  ·  Tinnitus (1)  ·  Vision Disorders (1)

Broader conditions

Eye Diseases (3)  ·  Nervous System Diseases (3)  ·  Neurologic Manifestations (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Sensation Disorders (3)  ·  Signs and Symptoms (3)  ·  Cranial Nerve Diseases (2)  ·  Vision Disorders (2)  ·  Autoimmune Diseases (1)  ·  Body Weight (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Dyskinesias (1)  ·  Ear Diseases (1)  ·  Endocrine System Diseases (1)

Interventions

4-Aminopyridine (1)  ·  Acetaminophen (1)  ·  Acetazolamide (1)  ·  Aspirin (1)  ·  Bupivacaine (1)  ·  Codeine (1)  ·  Ibuprofen (1)  ·  Naproxen (1)  ·  butalbital (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Smith-Kettlewell Eye Research Institute (1)  ·  St. Luke's-Roosevelt Hospital Center (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)

Top investigators

Alan B Scott, MD (1)  ·  Joel M Miller, PhD (1)  ·  Michael Wall, MD (1)

Results publications

PMID 20126486, PMID 24756302, PMID 24756514, PMID 24781936, PMID 25370510, PMID 25370513, PMID 26024112, PMID 26335066, PMID 26618282, PMID 26778344, PMID 26934136, PMID 27694262, PMID 28130349, PMID 28492874

NIH funding

U10EY017281 (1), U10EY017387 (1)